Case number 2019-1021
Galderma Laboratories, L.P. v. Amneal Pharmaceuticals LLC > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | GALDERMA LABORATORIES, L.P. v. AMNEAL PHARMACEUTICALS LLC [OPINION] [nonprecedential] (0) |
| Jun 2, 2020 | 95 | Mandate issued to the United States District Court for the District of Delaware. Service as of this date by the Clerk of Court. [698516] [JAB] [Entered: 06/02/2020 10:19 AM] (1) |
| May 26, 2020 | 94 | ORDER filed denying [93] petition for en banc rehearing filed by Amneal Pharmaceuticals LLC and Amneal Pharmaceuticals Co. (I) Pvt. Ltd. By: En Banc (Per Curiam). Service as of this date by the Clerk of Court. [696734] [JAB] [Entered: 05/26/2020 08:46 AM] (2) |
| Apr 23, 2020 | 93 | Petition for en banc rehearing filed by Appellants Amneal Pharmaceuticals Co. (I) Pvt. Ltd. and Amneal Pharmaceuticals LLC. Service: 04/23/2020 by email. [689533] [19-1021] [George Lombardi] [Entered: 04/23/2020 02:22 PM] (41) |
| Apr 23, 2020 | 92 | Amended Certificate of Interest for Appellants Amneal Pharmaceuticals LLC and Amneal Pharmaceuticals Co. (I) Pvt. Ltd.. Service: 04/23/2020 by email. [689529] [19-1021] [George Lombardi] [Entered: 04/23/2020 02:13 PM] (4) |
| Mar 25, 2020 | 91 | JUDGMENT. AFFIRMED-IN-PART AND REVERSED-IN-PART. Terminated on the merits after oral argument. COSTS: Each side bears its own costs. Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [681598] [JAB] [Entered: 03/25/2020 10:27 AM] (1) |
| Mar 25, 2020 | 90 | OPINION filed for the court by Lourie, Circuit Judge; Moore, Circuit Judge and Stoll, Circuit Judge. Nonprecedential Opinion. [681596] [JAB] [Entered: 03/25/2020 10:26 AM] (15) |
| Mar 25, 2020 | 89 | CONFIDENTIAL APPENDIX FILED (SUPPLEMENTAL) for Amneal Pharmaceuticals Co. (I) Pvt. Ltd. and Amneal Pharmaceuticals LLC. Number of Pages: 104. Service: 11/26/2019 by email. [681591] [JAB] [Entered: 03/25/2020 10:20 AM] (0) |
| Mar 25, 2020 | 88 | APPENDIX FILED (SUPPLEMENTAL) for Amneal Pharmaceuticals Co. (I) Pvt. Ltd. and Amneal Pharmaceuticals LLC. Number of Pages: 104. Service: 11/26/2019 by email. [681590] [JAB] [Entered: 03/25/2020 10:18 AM] (104) |
| Mar 25, 2020 | 87 | CONFIDENTIAL APPENDIX FILED (SUPPLEMENTAL) for Galderma Laboratories, L.P., Nestle Skin Health S.A. and TCD Royalty Sub LLC. Number of Pages: 65. Service: 11/21/2019 by email. [681587] [JAB] [Entered: 03/25/2020 10:14 AM] (0) |
| Mar 25, 2020 | 86 | APPENDIX FILED (SUPPLEMENTAL) for Galderma Laboratories, L.P., Nestle Skin Health S.A. and TCD Royalty Sub LLC. Number of Pages: 66. Service: 11/21/2019 by email. [681585] [JAB] [Entered: 03/25/2020 10:11 AM] (66) |
| Mar 25, 2020 | 85 | ORDER filed. The motions ([67], [68], [80], [83]) are granted. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [681579] [JAB] [Entered: 03/25/2020 09:52 AM] (2) |
| Nov 26, 2019 | 84 | Confidential CORRECTED MOTION TO FILE SUPPLEMENTAL APPENDIX AND SUPPLEMENT THE RECORD filed by Appellants Amneal Pharmaceuticals Co. (I) Pvt. Ltd. and Amneal Pharmaceuticals LLC corresponding to Doc. No. [83]. Service: 11/26/2019 by email, US mail. [652415] [19-1021] [Kevin Warner] [Entered: 11/26/2019 11:23 AM] (0) |
| Nov 26, 2019 | 83 | MOTION of Appellants Amneal Pharmaceuticals Co. (I) Pvt. Ltd. and Amneal Pharmaceuticals LLC to correct or supplement motion leave to file supplemental appendix [75], motion to correct/supplement [75] [Consent: unopposed]. Service: 11/26/2019 by email. [652409] [19-1021] [Kevin Warner] [Entered: 11/26/2019 11:17 AM] (117) |
| Nov 26, 2019 | 82 | Corrected Certificate of Service filed by Appellants Amneal Pharmaceuticals Co. (I) Pvt. Ltd. and Amneal Pharmaceuticals LLC to Doc No. [69]. Service: 11/26/2019 by email. [652394] [19-1021] [Kevin Warner] [Entered: 11/26/2019 10:44 AM] (1) |
| Nov 21, 2019 | 81 | Confidential CORRECTED MOTION FOR LEAVE TO FILE A SUPPLEMENTAL APPENDIX IN SUPPORT OF APPELLEES SUPPLEMENTAL BRIEF filed by Appellees Galderma Laboratories, L.P., Nestle Skin Health S.A. and TCD Royalty Sub LLC corresponding to Doc. No. [74]. Service: 11/21/2019 by email. [651471] [19-1021] [Gerald Flattmann] [Entered: 11/21/2019 04:38 PM] (0) |
| Nov 21, 2019 | 80 | MOTION of Appellees Galderma Laboratories, L.P., Nestle Skin Health S.A. and TCD Royalty Sub LLC to correct or supplement motion [73], leave to file a supplemental appendix [Consent: unopposed]. Service: 11/21/2019 by email. [651469] [19-1021] [Gerald Flattmann] [Entered: 11/21/2019 04:34 PM] (73) |
| Nov 21, 2019 | 79 | Corrected Certificate of Service filed by Appellees Galderma Laboratories, L.P., Nestle Skin Health S.A. and TCD Royalty Sub LLC to Doc No. [70]. Service: 11/21/2019 by email. [651466] [19-1021] [Gerald Flattmann] [Entered: 11/21/2019 04:29 PM] (1) |
| Nov 21, 2019 | 78 | NOTICE OF NON-COMPLIANCE: The submission of Amneal Pharmaceuticals Co. (I) Pvt. Ltd. and Amneal Pharmaceuticals LLC, Motion (nonconfidential [75], confidential [76]), is not in compliance with the rules of this court (see attached). Compliant document due 11/26/2019. Service as of this date by the Clerk of Court. [651236] [MJL] [Entered: 11/21/2019 11:52 AM] (2) |
| Nov 21, 2019 | 77 | NOTICE OF NON-COMPLIANCE: The submission of Galderma Laboratories, L.P., Nestle Skin Health S.A. and TCD Royalty Sub LLC, Motion (nonconfidential [73], confidential [74]), is not in compliance with the rules of this court (see attached). Compliant document due 11/26/2019. Service as of this date by the Clerk of Court. [651204]--[Edited 11/21/2019 by MJL to fix correction deadline] [MJL] [Entered: 11/21/2019 11:00 AM] (2) |
| Nov 19, 2019 | 76 | Confidential MOTION TO FILE SUPPLEMENTAL APPENDIX AND SUPPLEMENT THE RECORD filed by Appellants Amneal Pharmaceuticals Co. (I) Pvt. Ltd. and Amneal Pharmaceuticals LLC corresponding to Doc. No. [75], corresponding to Doc. No. [75]. Service: 11/19/2019 by email. [650723] [19-1021]. This motion is non-compliant. See Doc. No. [78]. [Kevin Warner] [Entered: 11/19/2019 09:02 PM] (0) |
| Nov 19, 2019 | 75 | MOTION of Appellants Amneal Pharmaceuticals Co. (I) Pvt. Ltd. and Amneal Pharmaceuticals LLC leave to file a supplemental appendix, to correct or supplement [Consent: unopposed]. Service: 11/19/2019 by email. [650722] [19-1021]. This motion is non-compliant. See Doc. No. [78]. [Kevin Warner] [Entered: 11/19/2019 08:56 PM] (117) |
| Nov 19, 2019 | 74 | Confidential MOTION FOR LEAVE TO FILE A SUPPLEMENTAL APPENDIX IN SUPPORT OF APPELLEES SUPPLEMENTAL BRIEF filed by Appellees Galderma Laboratories, L.P., Nestle Skin Health S.A. and TCD Royalty Sub LLC corresponding to Doc. No. [73]. Service: 11/19/2019 by email. [650714] [19-1021]. This motion is non-compliant. See Doc. No. [77] [Gerald Flattmann] [Entered: 11/19/2019 07:19 PM] (0) |
| Nov 19, 2019 | 73 | MOTION of Appellees Galderma Laboratories, L.P., Nestle Skin Health S.A. and TCD Royalty Sub LLC leave to file a supplemental appendix [Consent: unopposed]. Service: 11/19/2019 by email. [650712] [19-1021]. This motion is non-compliant. See Doc. No. [77] [Gerald Flattmann] [Entered: 11/19/2019 07:17 PM] (69) |
| Nov 19, 2019 | 72 | MODIFIED ENTRY: BRIEF FILED (SUPPLEMENTAL) for Galderma Laboratories, L.P., Nestle Skin Health S.A. and TCD Royalty Sub LLC. Number of Pages: 10. Service: 11/19/2019 by email. [650711] --[Edited 03/25/2020 by JAB - compliance review complete] [Gerald Flattmann] [Entered: 11/19/2019 07:04 PM] (21) |
| Nov 19, 2019 | 71 | MODIFIED ENTRY: BRIEF FILED (SUPPLEMENTAL) for Amneal Pharmaceuticals Co. (I) Pvt. Ltd. and Amneal Pharmaceuticals LLC. Number of Pages: 10. Service: 11/19/2019 by email. [650709] --[Edited 03/25/2020 by JAB - compliance review complete] [Kevin Warner] [Entered: 11/19/2019 07:03 PM] (19) |
| Nov 19, 2019 | 70 | MODIFIED ENTRY: CONFIDENTIAL BRIEF FILED (SUPPLEMENTAL) for Galderma Laboratories, L.P., Nestle Skin Health S.A. and TCD Royalty Sub LLC. Number of Pages: 10. Service: 11/19/2019 by email. [650708]--[Edited 03/25/2020 by JAB - compliance review complete] [Gerald Flattmann] [Entered: 11/19/2019 06:59 PM] (0) |
| Nov 19, 2019 | 69 | MODIFIED ENTRY: CONFIDENTIAL BRIEF FILED (SUPPLEMENTAL) for Amneal Pharmaceuticals Co. (I) Pvt. Ltd. and Amneal Pharmaceuticals LLC. Number of Pages: 10. Service: 11/19/2019 by email. [650707]--[Edited 03/25/2020 by JAB - compliance review complete] [Kevin Warner] [Entered: 11/19/2019 06:57 PM] (0) |
| Nov 19, 2019 | 68 | MOTION of Appellees Galderma Laboratories, L.P., Nestle Skin Health S.A. and TCD Royalty Sub LLC to waive confidentiality requirements [Consent: unopposed]. Service: 11/19/2019 by email. [650677] [19-1021] [Gerald Flattmann] [Entered: 11/19/2019 05:05 PM] (8) |
| Nov 19, 2019 | 67 | MOTION of Appellants Amneal Pharmaceuticals Co. (I) Pvt. Ltd. and Amneal Pharmaceuticals LLC to waive confidentiality requirements [Consent: unopposed]. Service: 11/19/2019 by email. [650658] [19-1021] [Kevin Warner] [Entered: 11/19/2019 04:36 PM] (8) |
| Nov 19, 2019 | 66 | Amended Certificate of Interest for Appellants Amneal Pharmaceuticals LLC and Amneal Pharmaceuticals Co. (I) Pvt. Ltd.. Service: 11/19/2019 by email. [650650] [19-1021] [Kevin Warner] [Entered: 11/19/2019 04:18 PM] (4) |
| Nov 14, 2019 | 65 | Amended Certificate of Interest for Appellees Galderma Laboratories, L.P., Nestle Skin Health S.A. and TCD Royalty Sub LLC. Service: 11/14/2019 by email. [649457] [19-1021] [Gerald Flattmann] [Entered: 11/14/2019 04:14 PM] (4) |
| Nov 5, 2019 | 64 | ORDER filed directing the parties to file supplemental briefs [see order for details]. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [647045] [JAB] [Entered: 11/05/2019 04:03 PM] (2) |
| Nov 4, 2019 | 63 | Confidential RESPONSE of Appellants Amneal Pharmaceuticals Co. (I) Pvt. Ltd. and Amneal Pharmaceuticals LLC to the supplemental authority filed by Appellees Galderma Laboratories, L.P., Nestle Skin Health S.A. and TCD Royalty Sub LLC filed by Appellants Amneal Pharmaceuticals Co. (I) Pvt. Ltd. and Amneal Pharmaceuticals LLC corresponding to Doc. No. [62]. Service: 11/04/2019 by email. [646677] [19-1021] [George Lombardi] [Entered: 11/04/2019 01:00 PM] (0) |
| Nov 4, 2019 | 62 | RESPONSE of Appellants Amneal Pharmaceuticals Co. (I) Pvt. Ltd. and Amneal Pharmaceuticals LLC to the supplemental authority [60] filed by Appellees Galderma Laboratories, L.P., Nestle Skin Health S.A. and TCD Royalty Sub LLC. Service: 11/04/2019 by email. [646667] [19-1021] [George Lombardi] [Entered: 11/04/2019 12:34 PM] (3) |
| Oct 31, 2019 | 61 | Confidential Citation of Supplemental Authority Pursuant to Fed. R. App. P. 28(j) filed by Appellees Galderma Laboratories, L.P., Nestle Skin Health S.A. and TCD Royalty Sub LLC corresponding to Doc. No. [60]. Service: 10/31/2019 by email. [646096] [19-1021] [Gerald Flattmann] [Entered: 10/31/2019 10:24 AM] (0) |
| Oct 31, 2019 | 60 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Appellees Galderma Laboratories, L.P., Nestle Skin Health S.A. and TCD Royalty Sub LLC. Service: 10/31/2019 by email. [646091] [19-1021] [Gerald Flattmann] [Entered: 10/31/2019 10:21 AM] (2) |
| Sep 5, 2019 | 59 | Submitted after ORAL ARGUMENT by Mr. George C. Lombardi, Esq. for Amneal Pharmaceuticals LLC and Amneal Pharmaceuticals Co. (I) Pvt. Ltd. and Gerald J. Flattmann, Jr. for Galderma Laboratories, L.P., Nestle Skin Health S.A. and TCD Royalty Sub LLC. Panel: Judge: Lourie , Judge: Moore , Judge: Stoll. [633251] [JCP] [Entered: 09/05/2019 10:13 AM] (0) |
| Aug 15, 2019 | 58 | Response to notice of oral argument from the Appellants Amneal Pharmaceuticals Co. (I) Pvt. Ltd. and Amneal Pharmaceuticals LLC. [628682] [19-1021] [George Lombardi] [Entered: 08/15/2019 04:04 PM] (3) |
| Aug 15, 2019 | 57 | Response to notice of oral argument from the Appellees Galderma Laboratories, L.P., Nestle Skin Health S.A. and TCD Royalty Sub LLC. [628626] [19-1021] [Gerald Flattmann] [Entered: 08/15/2019 03:19 PM] (3) |
| Jul 22, 2019 | 56 | NOTICE OF ORAL ARGUMENT. Panel: 1909G. Case scheduled September 05, 2019 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, NW Washington, DC 20439), Courtroom 201. Response to Notice of Oral Argument due: 08/15/2019. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. [622576] [JAB] [Entered: 07/22/2019 03:10 PM] (2) |
| Jul 17, 2019 | 55 | 6 paper copies of the Confidential Opening Response Brief [28] received from Appellees Galderma Laboratories, L.P., Nestle Skin Health S.A. and TCD Royalty Sub LLC. [621721] [CJF] [Entered: 07/17/2019 01:59 PM] (0) |
| Jul 16, 2019 | 54 | Notice to counsel for Appellees Galderma Laboratories, L.P., Nestle Skin Health S.A. and TCD Royalty Sub LLC: The record of this case indicates that the paper copies of the confidential brief [28] (see Fed. Cir. R. 30(a)(5) and Fed. Cir. R. 31(b)) have not been filed. The paper copies of the brief should be received by the court on or before 07/19/2019. Service as of this date by the Clerk of Court. [621347] [JAB] [Entered: 07/16/2019 01:32 PM] (0) |
| Jun 3, 2019 | 53 | Amended Certificate of Interest for the Appellants Amneal Pharmaceuticals Co. (I) Pvt. Ltd. and Amneal Pharmaceuticals LLC. Service: 06/03/2019 by email. [611012] [19-1021] [Kevin Warner] [Entered: 06/03/2019 02:42 PM] (4) |
| Mar 22, 2019 | 50 | Notice from Appellants Amneal Pharmaceuticals Co. (I) Pvt. Ltd. and Amneal Pharmaceuticals LLC regarding conflicts with oral argument. Service: 03/22/2019 by email. [595081] [19-1021] [George Lombardi] [Entered: 03/22/2019 05:12 PM] (3) |
| Mar 21, 2019 | 49 | Notice from Appellees Galderma Laboratories, L.P., Nestle Skin Health S.A. and TCD Royalty Sub LLC regarding conflicts with oral argument. Service: 03/21/2019 by email. [594490] [19-1021] [Gerald Flattmann] [Entered: 03/21/2019 01:23 PM] (3) |
| Mar 20, 2019 | 47 | 6 paper copies of the Confidential Reply Brief [37] received from Appellants Amneal Pharmaceuticals Co. (I) Pvt. Ltd. and Amneal Pharmaceuticals LLC. [594117] [CJF] [Entered: 03/20/2019 10:09 AM] (0) |
| Mar 20, 2019 | 48 | 6 paper copies of the Confidential Joint Appendix Brief (Vol. I - III) [40] received from Appellants Amneal Pharmaceuticals Co. (I) Pvt. Ltd. and Amneal Pharmaceuticals LLC. [594120] [CJF] [Entered: 03/20/2019 10:12 AM] (0) |
| Mar 20, 2019 | 46 | 6 paper copies of the Corrected Confidential Opening Brief [23] received from Appellants Amneal Pharmaceuticals Co. (I) Pvt. Ltd. and Amneal Pharmaceuticals LLC. [594111] [CJF] [Entered: 03/20/2019 10:04 AM] (0) |
| Mar 15, 2019 | 45 | Joint Statement of Compliance with Fed. Cir. R. 33 for Appellees Galderma Laboratories, L.P., Nestle Skin Health S.A., TCD Royalty Sub LLC and Appellants Amneal Pharmaceuticals LLC and Amneal Pharmaceuticals Co. (I) Pvt. Ltd.. Service: 03/15/2019 by email. [593185] [19-1021] [Kevin Warner] [Entered: 03/15/2019 12:27 PM] (3) |
| Mar 15, 2019 | 44 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The notice of conflict with oral argument is due on or before 03/22/2019. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [593148] [MMA] [Entered: 03/15/2019 11:12 AM] (1) |
| Mar 15, 2019 | 43 | Outstanding paper copies of all briefs and appendices must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(1). [593144] [MMA] [Entered: 03/15/2019 11:08 AM] (0) |
| Mar 14, 2019 | 42 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellees Galderma Laboratories, L.P., Nestle Skin Health S.A. and TCD Royalty Sub LLC. Service: 03/14/2019 by email. [592996] [19-1021] [Gerald Flattmann] [Entered: 03/14/2019 08:25 PM] (5) |
| Mar 14, 2019 | 41 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellants Amneal Pharmaceuticals Co. (I) Pvt. Ltd. and Amneal Pharmaceuticals LLC. Service: 03/14/2019 by email. [592995] [19-1021] [Kevin Warner] [Entered: 03/14/2019 07:47 PM] (3) |
| Mar 14, 2019 | 40 | MODIFIED ENTRY: CONFIDENTIAL JOINT APPENDIX FILED for Amneal Pharmaceuticals Co. (I) Pvt. Ltd. and Amneal Pharmaceuticals LLC. Number of Pages: 1149. Service: 03/14/2019 by email. [592992]--[Edited 03/15/2019 by MMA - Reason: compliance review complete] [Kevin Warner] [Entered: 03/14/2019 07:39 PM] (0) |
| Mar 14, 2019 | 39 | MODIFIED ENTRY: APPENDIX FILED for Amneal Pharmaceuticals Co. (I) Pvt. Ltd. and Amneal Pharmaceuticals LLC. Number of Pages: 1122. Service: 03/14/2019 by email. [592988] --[Edited 03/15/2019 by MMA - Reason: compliance review complete] [Kevin Warner] [Entered: 03/14/2019 07:27 PM] (1122) |
| Mar 7, 2019 | 38 | MODIFIED ENTRY: REPLY BRIEF FILED for Appellants Amneal Pharmaceuticals Co. (I) Pvt. Ltd. and Amneal Pharmaceuticals LLC. Number of Pages: 31. Service: 03/07/2019 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [591308] --[Edited 03/13/2019 by MMA - Reason: compliance review complete] [Kevin Warner] [Entered: 03/07/2019 07:15 PM] (44) |
| Mar 7, 2019 | 37 | MODIFIED ENTRY: CONFIDENTIAL REPLY BRIEF FILED for Appellants Amneal Pharmaceuticals Co. (I) Pvt. Ltd. and Amneal Pharmaceuticals LLC. Number of Pages: 31. Service: 03/07/2019 by email. [591306]--[Edited 03/13/2019 by MMA - Reason: compliance review complete] [Kevin Warner] [Entered: 03/07/2019 07:09 PM] (0) |
| Feb 20, 2019 | 36 | **TEXT ONLY** ORDER granting motion to withdraw attorney James Hilmert [35] filed by Appellants Amneal Pharmaceuticals LLC and Amneal Pharmaceuticals Co. (I) Pvt. Ltd. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [587487] [MMA] [Entered: 02/20/2019 02:57 PM] (0) |
| Feb 15, 2019 | 35 | MOTION of Appellants Amneal Pharmaceuticals Co. (I) Pvt. Ltd. and Amneal Pharmaceuticals LLC to withdraw counsel James M. Hilmert [Consent: opposed]. Service: 02/15/2019 by email. [586447] [19-1021] [Kevin Warner] [Entered: 02/15/2019 02:27 PM] (6) |
| Feb 14, 2019 | 34 | ORDER filed. The motion [26] is granted. The brief is accepted for filing. Service: 02/14/2019 by clerk. [585866] [NL] [Entered: 02/14/2019 11:04 AM] (2) |
| Feb 11, 2019 | 33 | ORDER filed. The motion [29] is granted. The appellants' reply brief is due March 7, 2019. Service: 02/11/2019 by clerk. [584934] [LMS] [Entered: 02/11/2019 03:43 PM] (2) |
| Feb 11, 2019 | 32 | ORDER filed. The motion [25] is granted. 2019-1093 is dismissed. Each side shall bear its own costs in 2019-1093. The revised official caption for 2019-1021 is reflected in the order. ISSUED AS A MANDATE (as to 2019-1093 only): February 11, 2019. Service: 02/11/2019 by clerk. [584925] [19-1021, 19-1093] [LMS] [Entered: 02/11/2019 03:32 PM] (2) |
| Feb 8, 2019 | 31 | RESPONSE of Appellants Amneal Pharmaceuticals Co. (I) Pvt. Ltd. and Amneal Pharmaceuticals LLC to the motion [26] filed by Cross-Appellants Galderma Laboratories, L.P., Nestle Skin Health S.A. and TCD Royalty Sub LLC. Service: 02/08/2019 by email. [584623] [19-1021] [Kevin Warner] [Entered: 02/08/2019 06:21 PM] (6) |
| Feb 8, 2019 | 30 | RESPONSE of Appellants Amneal Pharmaceuticals Co. (I) Pvt. Ltd. and Amneal Pharmaceuticals LLC to the motion to terminate appeal [25] filed by Cross-Appellants Galderma Laboratories, L.P., Nestle Skin Health S.A. and TCD Royalty Sub LLC. Service: 02/08/2019 by email. [584621] [19-1021] [Kevin Warner] [Entered: 02/08/2019 06:10 PM] (6) |
| Feb 8, 2019 | 29 | MOTION of Appellants Amneal Pharmaceuticals Co. (I) Pvt. Ltd. and Amneal Pharmaceuticals LLC to extend the time to 03/07/2019 to file the Reply Brief for Defendants-Appellants. [Consent: partial consent]. Service: 02/08/2019 by email. [584619] [19-1021] [Kevin Warner] [Entered: 02/08/2019 06:00 PM] (8) |
| Jan 31, 2019 | 28 | MODIFIED ENTRY: CONFIDENTIAL BRIEF FILED for Appellees Galderma Laboratories, L.P., Nestle Skin Health S.A. and TCD Royalty Sub LLC. Number of Pages: 62. Service: 01/31/2019 by email. [582584]--[Edited 02/14/2019 by MMA - Reason: compliance review complete] [Gerald Flattmann] [Entered: 01/31/2019 11:08 PM] (0) |
| Jan 31, 2019 | 27 | MODIFIED ENTRY: BRIEF FILED for Appellees Galderma Laboratories, L.P., Nestle Skin Health S.A. and TCD Royalty Sub LLC. Number of Pages: 62. Service: 01/31/2019 by email. [582583] --[Edited 02/14/2019 by MMA - Reason: compliance review complete] [Gerald Flattmann] [Entered: 01/31/2019 11:05 PM] (77) |
| Jan 31, 2019 | 26 | MOTION of Cross-Appellants Galderma Laboratories, L.P., Nestle Skin Health S.A. and TCD Royalty Sub LLC to waive confidentiality requirements [Consent: opposed]. Service: 01/31/2019 by email. [582582] [19-1021] [Gerald Flattmann] [Entered: 01/31/2019 11:00 PM] (10) |
| Jan 31, 2019 | 25 | MOTION of Cross-Appellants Galderma Laboratories, L.P., Nestle Skin Health S.A. and TCD Royalty Sub LLC to terminate appeal through Voluntary Dismissal (FRAP 42(b)). Cases to be terminated: Cross-Appeal No. 19-1093 [Consent: opposed]. Service: 01/31/2019 by email. [582581] [19-1021] [Gerald Flattmann] [Entered: 01/31/2019 10:56 PM] (7) |
| Jan 7, 2019 | 24 | MODIFIED ENTRY:CORRECTED BRIEF FILED for Appellants Amneal Pharmaceuticals Co. (I) Pvt. Ltd. and Amneal Pharmaceuticals LLC. Number of Pages: 65. Service: 01/07/2019 by email. [576481] --[Edited 01/10/2019 by MMA - Reason: compliance review complete] [Kevin Warner] [Entered: 01/07/2019 04:57 PM] (327) |
| Jan 7, 2019 | 23 | MODIFIED ENTRY:CORRECTED CONFIDENTIAL BRIEF FILED for Appellants Amneal Pharmaceuticals Co. (I) Pvt. Ltd. and Amneal Pharmaceuticals LLC. Number of Pages: 65. Service: 01/07/2019 by email. [576479]--[Edited 01/10/2019 by MMA - Reason: compliance review complete] [Kevin Warner] [Entered: 01/07/2019 04:54 PM] (0) |
| Jan 7, 2019 | 22 | Notice of Correction to the confidential Brief Doc No. [20], Opening Brief Doc No. [20] for Appellants Amneal Pharmaceuticals Co. (I) Pvt. Ltd. and Amneal Pharmaceuticals LLC. Service: 01/07/2019 by email. [576477] [19-1021] [Kevin Warner] [Entered: 01/07/2019 04:50 PM] (5) |
| Dec 20, 2018 | 21 | MODIFIED ENTRY: BRIEF FILED for Appellants Amneal Pharmaceuticals Co. (I) Pvt. Ltd. and Amneal Pharmaceuticals LLC. Number of Pages: 65. Service: 12/20/2018 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [573789] --[compliance review complete - Edited 01/03/2019 by SMJ] [Kevin Warner] [Entered: 12/20/2018 06:06 PM] (331) |
| Dec 20, 2018 | 20 | MODIFIED ENTRY: CONFIDENTIAL BRIEF FILED for Appellants Amneal Pharmaceuticals Co. (I) Pvt. Ltd. and Amneal Pharmaceuticals LLC. Number of Pages: 65. Service: 12/20/2018 by email. [573788]--[compliance review complete - Edited 01/03/2019 by SMJ] [Kevin Warner] [Entered: 12/20/2018 06:04 PM] (0) |
| Dec 17, 2018 | 19 | Entry of appearance for Maureen L. Rurka as of counsel for Appellants Amneal Pharmaceuticals Co. (I) Pvt. Ltd. and Amneal Pharmaceuticals LLC. Service: 12/17/2018 by email. [572349] [19-1021] [Maureen Rurka] [Entered: 12/17/2018 04:24 PM] (2) |
| Dec 17, 2018 | 18 | Entry of appearance for James M. Hilmert as of counsel for Appellants Amneal Pharmaceuticals Co. (I) Pvt. Ltd. and Amneal Pharmaceuticals LLC. Service: 12/17/2018 by email. [572345] [19-1021] [James Hilmert] [Entered: 12/17/2018 04:18 PM] (2) |
| Nov 20, 2018 | 17 | **TEXT ONLY** ORDER granting motion to extend time to file brief [16] filed by Cross-Appellants Galderma Laboratories, L.P., Nestle Skin Health S.A. and TCD Royalty Sub LLC. Appellants' opening brief is due 12/20/2018. Cross-Appellants opening brief is due 01/31/2019. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [566616] [SJ] [Entered: 11/20/2018 10:03 AM] (0) |
| Nov 14, 2018 | 16 | MOTION of Cross-Appellants Galderma Laboratories, L.P., Nestle Skin Health S.A. and TCD Royalty Sub LLC to extend the time to 12/20/2018 to file the Appellant Initial Brief. [Consent: unopposed]. Service: 11/14/2018 by email. [564980] [19-1021] [Gerald Flattmann] [Entered: 11/14/2018 05:10 PM] (11) |
| Oct 31, 2018 | 15 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:attorney entry of appearance Docket No. [10], ERROR: Attorney Evan Diamond has not updated his information in CM/ECF. CORRECTION: Counsel should promptly update his information in CM/ECF to match the information on his entry of appearance. [561640] [MMA] [Entered: 10/31/2018 01:34 PM] (0) |
| Oct 31, 2018 | 14 | Entry of appearance for Vanessa Yen as of counsel for Cross-Appellants Galderma Laboratories, L.P., Nestle Skin Health S.A. and TCD Royalty Sub LLC. Service: 10/31/2018 by email. [561619] [19-1021] [Vanessa Yen] [Entered: 10/31/2018 12:02 PM] (2) |
| Oct 19, 2018 | 13 | Sealed or confidential document received [Sealed 8/27/18 Opinion] from district court (Delaware). Service: 10/16/2018 by email. [558724] [SJ] [Entered: 10/19/2018 11:20 AM] (0) |
| Oct 19, 2018 | 12 | Official caption revised to reflect cross-appeal by plaintiffs. The official caption is reflected on the electronic docket under the listing of the parties and counsel. Service as of this date by the Clerk of Court. [558717] [SJ] [Entered: 10/19/2018 11:11 AM] (0) |
| Oct 19, 2018 | 11 | Note to file: The following cases are associated:19-1021 (lead) with 19-1093 (cross). FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [558716] [19-1021, 19-1093] [SJ] [Entered: 10/19/2018 11:11 AM] (0) |
| Oct 18, 2018 | 10 | Entry of appearance for Evan Diamond as of counsel for Appellees Galderma Laboratories, L.P., Nestle Skin Health S.A. and TCD Royalty Sub LLC. Service: 10/18/2018 by email. [558612] [19-1021] [Evan Diamond] [Entered: 10/18/2018 06:08 PM] (2) |
| Oct 18, 2018 | 9 | Certificate of Interest for the Appellees Galderma Laboratories, L.P., Nestle Skin Health S.A. and TCD Royalty Sub LLC. Service: 10/18/2018 by email. [558611] [19-1021] [Gerald Flattmann] [Entered: 10/18/2018 06:03 PM] (4) |
| Oct 18, 2018 | 8 | Docketing Statement for the Appellees Galderma Laboratories, L.P., Nestle Skin Health S.A. and TCD Royalty Sub LLC. Service: 10/18/2018 by email. [558608] [19-1021] [Gerald Flattmann] [Entered: 10/18/2018 05:58 PM] (4) |
| Oct 18, 2018 | 7 | Entry of appearance for Gerald J. Flattmann, Jr. as principal counsel for Appellees Galderma Laboratories, L.P., Nestle Skin Health S.A. and TCD Royalty Sub LLC. Service: 10/18/2018 by email. [558607] [19-1021] [Gerald Flattmann] [Entered: 10/18/2018 05:56 PM] (2) |
| Oct 18, 2018 | 6 | Docketing Statement for the Appellants Amneal Pharmaceuticals Co. (I) Pvt. Ltd. and Amneal Pharmaceuticals LLC. Service: 10/18/2018 by email. [558532] [19-1021] [Kevin Warner] [Entered: 10/18/2018 03:06 PM] (7) |
| Oct 18, 2018 | 5 | Certificate of Interest for the Appellants Amneal Pharmaceuticals Co. (I) Pvt. Ltd. and Amneal Pharmaceuticals LLC. Service: 10/18/2018 by email. [558530] [19-1021] [Kevin Warner] [Entered: 10/18/2018 03:01 PM] (4) |
| Oct 18, 2018 | 4 | Entry of appearance for Kevin E. Warner as of counsel for Appellants Amneal Pharmaceuticals Co. (I) Pvt. Ltd. and Amneal Pharmaceuticals LLC. Service: 10/18/2018 by email. [558524] [19-1021] [Kevin Warner] [Entered: 10/18/2018 02:55 PM] (2) |
| Oct 18, 2018 | 3 | Entry of appearance for George C. Lombardi as principal counsel for Appellants Amneal Pharmaceuticals Co. (I) Pvt. Ltd. and Amneal Pharmaceuticals LLC. Service: 10/18/2018 by email. [558521] [19-1021] [George Lombardi] [Entered: 10/18/2018 02:49 PM] (2) |
| Oct 18, 2018 | 2 | Entry of appearance for Eimeric Reig-Plessis as of counsel for Appellants Amneal Pharmaceuticals Co. (I) Pvt. Ltd. and Amneal Pharmaceuticals LLC. Service: 10/18/2018 by email. [558518] [19-1021] [Eimeric Reig-Plessis] [Entered: 10/18/2018 02:39 PM] (2) |
| Oct 4, 2018 | 1 | Appeal docketed. Received: 10/02/2018. [554871]Entry of Appearance due 10/18/2018. Certificate of Interest is due on 10/18/2018. Docketing Statement due 10/18/2018. Appellant/Petitioner's brief is due 12/03/2018. [SJ] [Entered: 10/04/2018 01:10 PM] (35) |
